Skip to main content
Premium Trial:

Request an Annual Quote

BioServe, NeoCodex Ink Co-Marketing Deal for Each Other's Tissue Banks

NEW YORK (GenomeWeb News) — Human tissue repository companies BioServe and NeoCodex have penned an agreement that will enable the firms to distribute each other’s products.
 
Terms of the deal give BioServe access to NeoCodex’s bio-repository of DNA, FFPE, fluid, and tissue samples collected from Spain’s "uniquely homogenous” population.
 
In return, NeoCodex will gain access to BioServe’s Global Repository, a 600,000-sample bank of tissue, DNA, and serum “linked to detailed clinical and demographic data” from 140,000 patients collected on four continents.
 
Financial terms of the agreement were not released.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.